Reacyl.com is available for acquisition
reacyl.com
A concise, science-oriented .com name for biotech, molecular research, acylation intelligence and drug-discovery platforms.
No fixed public price. No payment is collected on this website.
Positioning
A focused name for molecular science.
Reacyl.com is a short, brandable domain with a natural connection to acylation, molecular modification and biochemical research. Its structure makes it suitable for companies, platforms or product lines working across biotech, drug discovery, lipidomics, protein modification, medicinal chemistry or AI-supported molecular design.
Possible industries
- Biotech research tools
- Drug discovery and pharma R&D
- Lipidomics, metabolomics and molecular science platforms
Possible use cases
- Acylation intelligence or molecular modification platform
- AI-supported drug-discovery or medicinal chemistry tool
- Protein modification, lipidomics or metabolomics analytics product
Mini-brand direction
A name built for precise scientific positioning.
Reacyl could support a molecular research platform, an acylation analytics product, a drug-discovery tool, a lipidomics system or a specialized biotech software brand. Its value lies in the combination of brevity, scientific relevance and strong .com presentation.
Why the name works
Reacyl is short, distinctive and science-oriented. The name evokes acyl, acylation and re-acylation, making it especially relevant for molecular research, biochemical modification and discovery-oriented platforms. It is compact enough for a strong wordmark, specific enough to feel credible in biotech and chemistry contexts, and flexible enough to support a product, platform or specialized research tool without being tied to one narrow application.
Secure transfer process
No payment is collected on this website. If an agreement is reached, the final transaction will be handled through Sedo, Escrow.com or a comparable trusted domain transfer / escrow service. The domain will only be transferred after secure payment confirmation.
Make offer
Submit a private acquisition inquiry
Send your offer or inquiry. We will review it and respond by email if there is a potential fit.